Etude de la faisabilité de création d’une spin-off biotechnologique active dans le domaine de la production industrielle de vaccins recombinants

Details

Supervisors

Coeurderoy, Régis ; Soumillion, Patrice ; Lambrecht, Philippe

Faculty

Louvain School of Management
Faculté de droit et de criminologie

Degree label

Master [120] en ingénieur de gestion
Master [120] en droit

Abstract

This document is the result of a multidisciplinary analysis about the creation of a spin-off. Our core business is based on the licencing of a patented technology, filed by the Université libre de Bruxelles. The aforementioned patent describes a technology that allows improvement in the control of the quality of recombinant proteins during industrial production. More specifically, our target market is recombinant-based vaccines manufactured by major pharmaceutical companies. Indeed, industrials are subject to dramatic control measures by the competent authorities for the delivery of vaccines. High quality standards are required in order to release a batch and for it to be allowed to be sold. The purification process that is needed to reach these standards often leads to the disposal of a significative part of the production. The goal of our technology is, as we said, to improve the quality of recombinant proteins. By doing so, we aim to improve the total yield on a production, lower the production costs, hence the selling price.